TOP TIERMARKET NEWSWIRE
News & sentiment

ALKERMES PLC (ALKS) — News & AI sentiment

ALKERMES PLC (ALKS) news roundup. 6 stories aggregated over the last 30 days. Average 30-day sentiment is 58/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 7 sales totalling $3.8M — net selling of $3.8M. US House Periodic Transaction Reports (90-day window): 4 purchases (~$57K) and 1 sale (~$75K). Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
6
avg sentiment 58/100
Insider net (90d)
$3.8M
0 buys · 7 sells
Congress (90d)
3
4 buys · 1 sells

ALKS news in the last 24 hours, 7 days, 30 days and 90 days

How much ALKS coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowALKS storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days658/100ALKS headlines →
Last 90 days4256.5/100ALKS headlines →

Latest stories on ALKS

Oct 20
Oct 16
Oct 13
Oct 13
Oct 7
Stifel reiterates Alkermes stock rating on pipeline confidence
Investing.com Analyst Ratings56 · neutralanalyst
Oct 5
Sep 26
Goldman Sachs resumes Alkermes stock coverage with neutral rating
Investing.com Analyst Ratings50 · neutralanalyst
Sep 24
Sep 24
Sep 23
Sep 22
Sep 21
TD Cowen reiterates Alkermes stock Buy rating on ADHD trial data
Investing.com Analyst Ratings61 · neutralanalyst
Sep 21
Sep 21
Stifel reiterates Alkermes stock rating on ADHD drug trial data
Investing.com Analyst Ratings56 · neutralanalyst
Sep 21
Sep 21
Sep 21
Sep 21
Why is Alkermes stock surging today?
Investing.com Markets50 · neutralgeneral
Sep 21
Alkermes stock jumps on positive ADHD drug trial results
Investing.com Markets73 · bullishproduct/pr
Sep 21
Alkermes plc. (ALKS) files 8-K
SEC 8-K50 · neutralgeneral
Sep 21
Sep 21
Alkermes slides 7%, reaching multi-month low
Seeking Alpha34 · bearishgeneral
Sep 18
Alkermes plc. (ALKS) files 8-K
SEC 8-K50 · neutralgeneral
Sep 16
Sep 16
Open ALKS in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →